Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease-Reference-Cited by-同舟云学术

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

Published:2018-03-09 Issue:1 Volume:12 Page:129-138
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Holdstock Louis¹,Cizman Borut²³,Meadowcroft Amy M¹,Biswas Nandita²,Johnson Brendan M⁴,Jones Delyth⁵,Kim Sung Gyun⁶,Zeig Steven⁷,Lepore John J²,Cobitz Alexander R²

Affiliation:

1. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Research Triangle Park, NC, USA

2. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Collegeville, PA, USA

3. Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

4. Clinical Pharmacology, Roivant Sciences Inc., Durham, NC, USA

5. Clinical Statistics, GlaxoSmithKline, Stevenage, UK

6. Hallym University Sacred Heart Hospital, Anyang, South Korea

7. Pines Clinical Research, Pembroke Pines, FL, USA

Funder

clinicaltrials.gov

EudraCT

GSK registry

GlaxoSmithKline

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/12/1/129/27721405/sfy013.pdf

Reference28 articles.

1. New treatment approaches for the anemia of CKD;Bonomini;Am J Kidney Dis,2016

2. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006

3. Normalization of hemoglobin level in patients with chronic kidney disease and anemia;Drüeke;N Engl J Med,2006

4. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease;Pfeffer;N Engl J Med,2009

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-07-10

2. Investigational new drugs for the treatment of chronic renal failure: an overview of the literature;Expert Opinion on Investigational Drugs;2024-03-28

3. Daprodustat and Heart Failure in CKD;Journal of the American Society of Nephrology;2024-02-22

4. Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI);Advances in Therapy;2024-01-27

5. Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease;Frontiers in Pharmacology;2023-12-06